Both hypothalamic nuclei have been proved to be preserved in patients with TDP-43 (TAR DNA-binding protein 43) proteinopathy [78], suggesting possible differential responses to oxytocin treatments according to the underlying molecular pathologies. This evidence concerns the gene TARDBP and proteostasis deficiencies.